We have located links that may give you full text access.
JOURNAL ARTICLE
REVIEW
Managing muscle-invasive bladder cancer in the elderly.
Expert Review of Anticancer Therapy 2010 June
Bladder cancer is inherently a disease of the elderly with the highest incidence occurring in the eighth decade of life. Approximately a third of the 70,000 patients diagnosed with bladder cancer in the USA in 2009 will have presented with muscle-invasive bladder cancer (MIBC) requiring aggressive management. Left untreated, most patients with MIBC suffer significant morbidity and die of the disease within 2 years of the diagnosis. While radical cystectomy, the best treatment option for local control of bladder cancer, has been shown to be safe in the elderly, outcomes depend more heavily on the functional status of the patient than on chronologic age. The current literature suffers from a focus on chronologic age versus functional age in assessing outcomes, selection bias introduced by evaluating retrospective cohorts and limited data on outcomes of alternative treatment options in the elderly. In addition, a focus on disease-specific and overall survival leaves limited information regarding the quality of life of patients following aggressive management of MIBC. In this article, we review current issues regarding the definition of the elderly, summarize the reported literature on outcomes for elderly patients by treatment approach and discuss limitations and recommendations for the management of elderly patients with MIBC.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app